Teva And Alvotech Confirm Quallent Deal On US Adalimumab

Follows Announcement By Cigna’s Evernorth Of $0 Out-Of-Pocket Scheme For Biosimilar

 
• By David Wallace
  
Handshake of businessmen
Alvotech and Teva have confirmed their deal with Quallent
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business